We performed the cytotoxicity studies of the synthesized Compounds 1–5 and sodium orthovanadate (as a standard inhibitor of PTP1B) against the MCF-7 and MDA-MB-231 breast cancer cell lines, as well as the human keratinocyte HaCaT cell line (as a noncancerous control). Here, PTPN1 is linked to breast carcinoma.